Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740512
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)Polaryx Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07740512Not Yet Recruiting
Phase 2
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in P...Polaryx Therapeutics, Inc...
NCT07739238
THE EFFECTS OF DIFFERENT BREATHING EXERCISES ON RESPIRATORY PARAMETERS AND HEART RATE VARIABILITYBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07739238Recruiting
Not Applicable
THE EFFECTS OF DIFFERENT BREATHING EXERCISES ON RESPIRATORY PARAMETERS AND HEART...Bandırma Onyedi Eylül Uni...
NCT07740629
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?Yair DaykanNot Yet RecruitingNot Applicable
NCT07740629Not Yet Recruiting
Not Applicable
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anx...Yair Daykan
NCT07739329
A Study on the Preventive Effect of Electroacupuncture Combined With Dexmedetomidine in Post-stroke DepressionMin SuNot Yet RecruitingPhase 4
NCT07739329Not Yet Recruiting
Phase 4
A Study on the Preventive Effect of Electroacupuncture Combined With Dexmedetomi...Min Su
NCT07738861
Effect of Intraoperative Tetracycline on Postoperative Pain After Mandibular Molar ExtractionCMH Lahore Medical College and Institute of DentistryCompletedPhase 4
NCT07738861Completed
Phase 4
Effect of Intraoperative Tetracycline on Postoperative Pain After Mandibular Mol...CMH Lahore Medical Colleg...
NCT07739498
Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander in Early AdolescentsMansoura UniversityRecruitingNot Applicable
NCT07739498Recruiting
Not Applicable
Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander...Mansoura University
NCT07738679
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not Yet RecruitingPhase 2
NCT07738679Not Yet Recruiting
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Particip...Chia Tai Tianqing Pharmac...
NCT07738315
Elemene Liposomes in Endometrial CancerBeijing Friendship HospitalNot Yet RecruitingPhase 2
NCT07738315Not Yet Recruiting
Phase 2
Elemene Liposomes in Endometrial CancerBeijing Friendship Hospit...
NCT07738939
IKS04 Regimen in Advanced Solid Tumors That Express CA242Iksuda Therapeutics Ltd.Not Yet RecruitingPhase 1
NCT07738939Not Yet Recruiting
Phase 1
IKS04 Regimen in Advanced Solid Tumors That Express CA242Iksuda Therapeutics Ltd.
NCT07739277
Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast SurgeryAnkara Etlik City HospitalNot Yet RecruitingNot Applicable
NCT07739277Not Yet Recruiting
Not Applicable
Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast SurgeryAnkara Etlik City Hospita...
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07739927
Serrated Inferior Turbinate Variation and Sinonasal Findings on CBCTRecep Tayyip Erdogan University Training and Research HospitalNot Yet Recruiting
NCT07739927Not Yet Recruiting
—
Serrated Inferior Turbinate Variation and Sinonasal Findings on CBCTRecep Tayyip Erdogan Univ...
NCT07739550
Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in WomenAl-Azhar UniversityNot Yet RecruitingNot Applicable
NCT07739550Not Yet Recruiting
Not Applicable
Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in WomenAl-Azhar University
NCT07738276
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityShahid Beheshti University of Medical SciencesNot Yet RecruitingPhase 3
NCT07738276Not Yet Recruiting
Phase 3
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist,...Shahid Beheshti Universit...
NCT07740421
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Efficacy of NH002 as a Contrast Agent Administrated Via Intravenous Bolus Injection and Infusion for Subjects Undergoing Cardiac EchocardiographySyneos HealthNot Yet RecruitingPhase 3
NCT07740421Not Yet Recruiting
Phase 3
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Effi...Syneos Health
NCT07738159
Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine CarcinomaWest China HospitalNot Yet RecruitingPhase 2
NCT07738159Not Yet Recruiting
Phase 2
Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extra...West China Hospital
NCT07740317
Neurocognitive Trajectories After BCMA CAR-TAtrium Health Wake Forest BaptistNot Yet Recruiting
NCT07740317Not Yet Recruiting
—
Neurocognitive Trajectories After BCMA CAR-TAtrium Health Wake Forest...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07740031
Development of a Frailty Risk Prediction Model and Preliminary Evaluation of a Risk-stratified Social Robot-assisted Intervention in Middle-aged and Older Spousal CaregiversThe Hong Kong Polytechnic UniversityNot Yet RecruitingNot Applicable
NCT07740031Not Yet Recruiting
Not Applicable
Development of a Frailty Risk Prediction Model and Preliminary Evaluation of a R...The Hong Kong Polytechnic...
Result Breakdown
Not yet recruiting16 (80%)
Recruiting2 (10%)
Completed2 (10%)
not_applicable7 (35%)
Phase 25 (25%)
Not Specified3 (15%)
Phase 42 (10%)
Phase 32 (10%)
Phase 11 (5%)